99 related articles for article (PubMed ID: 6576995)
1. Studies on the differentiation inducers of myeloid leukemic cells. III. Spicamycin, a new inducer of differentiation of HL-60 human promyelocytic leukemia cells.
Hayakawa Y; Nakagawa M; Kawai H; Tanabe K; Nakayama H; Shimazu A; Seto H; Otake N
J Antibiot (Tokyo); 1983 Jul; 36(7):934-7. PubMed ID: 6576995
[No Abstract] [Full Text] [Related]
2. Spicamycin and KRN5500 induce apoptosis in myeloid and lymphoid cell lines with down-regulation of bcl-2 expression and modulation of promyelocytic leukemia protein.
Zhang WJ; Ohnishi K; Yoshida H; Pan L; Maksumova L; Muratkhodjaev F; Luo JM; Shigeno K; Fujisawa S; Naito K; Nakamura S; Shinjo K; Takeshita A; Ohno R
Jpn J Cancer Res; 2000 Jun; 91(6):604-11. PubMed ID: 10874212
[TBL] [Abstract][Full Text] [Related]
3. Induction of differentiation of human promyelocytic leukemia cells (HL-60) by nucleosides and methotrexate.
Bodner AJ; Ting RC; Gallo RC
J Natl Cancer Inst; 1981 Nov; 67(5):1025-30. PubMed ID: 6946245
[TBL] [Abstract][Full Text] [Related]
4. [Differentiation of human promyelocytic leukemic cells (HL-60) induced by aclacinomycin-B].
Lu Y; Han J; Liu HY; Zhong GP; Yang S; Jia TZ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1986 Jun; 8(3):211-3. PubMed ID: 2946461
[No Abstract] [Full Text] [Related]
5. Structure-activity relationships for the induction of differentiation of HL-60 human acute promyelocytic leukemia cells by anthracyclines.
Schwartz EL; Sartorelli AC
Cancer Res; 1982 Jul; 42(7):2651-5. PubMed ID: 6952957
[TBL] [Abstract][Full Text] [Related]
6. Structure-antitumor activity relationship of semi-synthetic Spicamycin derivatives.
Sakai T; Kawai H; Kamishohara M; Odagawa A; Suzuki A; Uchida T; Kawasaki T; Tsuruo T; Otake N
J Antibiot (Tokyo); 1995 Dec; 48(12):1467-80. PubMed ID: 8557605
[TBL] [Abstract][Full Text] [Related]
7. Anicemycin, a new inhibitor of anchorage-independent growth of tumor cells from Streptomyces sp. TP-A0648.
Igarashi Y; Ootsu K; Onaka H; Fujita T; Uehara Y; Furumai T
J Antibiot (Tokyo); 2005 May; 58(5):322-6. PubMed ID: 16060384
[TBL] [Abstract][Full Text] [Related]
8. Studies on the differentiation inducers of myeloid leukemic cells. I. Latosillan, a new inducer of the differentiation of M1 cells.
Hayakawa Y; Nakagawa M; Ando T; Shimazu A; Seto H; Otake N
J Antibiot (Tokyo); 1982 Sep; 35(9):1252-4. PubMed ID: 6958671
[No Abstract] [Full Text] [Related]
9. New facts and speculations on human myeloid leukemias.
Breitman TR; Gallo RC
Blood Cells; 1981; 7(1):79-89. PubMed ID: 6964818
[TBL] [Abstract][Full Text] [Related]
10. Terminal differentiation of the human promyelocytic leukemia cell line, HL-60, in the absence of cell proliferation.
Ferrero D; Tarella C; Gallo E; Ruscetti FW; Breitman TR
Cancer Res; 1982 Nov; 42(11):4421-6. PubMed ID: 6957259
[TBL] [Abstract][Full Text] [Related]
11. [Changes of fibrinolytic activity of human HL60 acute leukemia cells responses to chemically induced differentiation].
Ghezzo F; Palumbo A; Pegoraro L
Boll Soc Ital Biol Sper; 1980 Jul; 56(13):1355-9. PubMed ID: 6934784
[TBL] [Abstract][Full Text] [Related]
12. Effect of antimetabolites and thymidine blockage on the induction of differentiation of HL-60 cells by retinoic acid or 1 alpha,25-dihydroxyvitamin D3.
Ishikura H; Okazaki T; Mochizuki T; Izumi Y; Tashima M; Sawada H; Uchino H
Exp Hematol; 1985 Nov; 13(10):981-8. PubMed ID: 3932088
[TBL] [Abstract][Full Text] [Related]
13. Induction of leukemia cell differentiation by chemotherapeutic agents.
Schwartz EL; Ishiguro K; Sartorelli AC
Adv Enzyme Regul; 1983; 21():3-20. PubMed ID: 6400065
[TBL] [Abstract][Full Text] [Related]
14. Induction of differentiation of human promyelocytic leukemia cells (HL-60) by arginase.
Honma Y; Fujita Y; Okabe-Kado J; Kasukabe T; Hozumi M
Cancer Lett; 1980 Oct; 10(4):287-92. PubMed ID: 6933000
[TBL] [Abstract][Full Text] [Related]
15. Biosynthesis of 4-aminoheptose 2-epimers, core structural components of the septacidins and spicamycins.
Price NP; Furukawa T; Cheng F; Qi J; Chen W; Crich D
J Antibiot (Tokyo); 2014 May; 67(5):405-14. PubMed ID: 24643053
[TBL] [Abstract][Full Text] [Related]
16. Evidence for cell cycle phase-specific initiation of a program of HL-60 cell myeloid differentiation mediated by inducer uptake.
Yen A; Albright KL
Cancer Res; 1984 Jun; 44(6):2511-5. PubMed ID: 6327017
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of glycoprotein biosynthesis by the inducers of HL-60 cell differentiation, aclacinomycin A and marcellomycin.
Morin MJ; Sartorelli AC
Cancer Res; 1984 Jul; 44(7):2807-12. PubMed ID: 6327026
[TBL] [Abstract][Full Text] [Related]
18. Normal functional characteristics of cultured human promyelocytic leukemia cells (HL-60) after induction of differentiation by dimethylsulfoxide.
Collins SJ; Ruscetti FW; Gallagher RE; Gallo RC
J Exp Med; 1979 Apr; 149(4):969-74. PubMed ID: 219131
[TBL] [Abstract][Full Text] [Related]
19. Induction of differentiation of human myeloid leukemia HL-60 cells by novel pyrimidine nucleoside analogs.
Makishima M; Honma Y; Hozumi M; Sampi K; Hattori M; Ishikawa I; Ogura H; Kawahara N; Kanaiwa T; Motoyoshi K
Biochim Biophys Acta; 1991 Aug; 1094(1):1-7. PubMed ID: 1883847
[TBL] [Abstract][Full Text] [Related]
20. Induction of granulocyte differentiation in a human leukemia cell line does not require cell division.
Prokocimer M; Koeffler HP
Haematologia (Budap); 1986; 19(2):127-32. PubMed ID: 3463527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
